WASHINGTON (dpa-AFX) - IDEXX Laboratories Inc. (IDXX), a developer of veterinary diagnostics, software and water testing solutions, reported higher second-quarter profit, driven by strong revenue growth. The company also narrowed its full-year revenue outlook and lifter EPS guidance.
Net income attributable to stockholders increased to $338.41 million, or $4.27 per share, from $293.99 million, or $3.63 per share a year earlier.
Income from operations climbed to $425.57 million from $373.05 million in the prior-year quarter.
Revenue rose 9.7% to $1.217 billion from $1.109 billion last year.
Looking ahead, IDEXX narrowed its full-year 2026 revenue guidance to a range of $4.700 billion to $4.745 billion, compared with its previous forecast of $4.675 billion to $4.760 billion.
The company also raised its earnings outlook, now expecting earnings per share of $14.69 to $14.94, compared with its prior guidance of $14.45 to $14.90.
IDEXX shares were up about 3% in pre-market trading after closing at $567.84 on Monday.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
